Advertisement

Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus.

17:30 EDT 18th May 2013 | BioPortfolio

Summary of "Risk factors associated with mupirocin resistance in meticillin-resistant Staphylococcus aureus."

Implementation of meticillin-resistant Staphylococcus aureus (MRSA) decolonisation programmes has been increasing and the emergence of mupirocin resistance has been reported. However, the patient-level risk factors associated with mupirocin resistance are not clear. In this study, independent predictors of mupirocin resistance in MRSA among Providence Veterans Affairs Medical Center patients with MRSA-positive culture dates between 1 July 2004 and 30 June 2008 were identified using a frequency-matched case-control study. Forty cases (mupirocin-resistant) were matched on culture date quarter and year to 270 controls (mupirocin-susceptible). The adjusted conditional logistic regression model identified three significant independent predictors associated with mupirocin resistance in
MRSA:
(1) exposure to mupirocin in the year prior to the culture date [odds ratio (OR): 9.84; 95% confidence interval (CI): 2.93-33.09]; (2) Pseudomonas aeruginosa infection in the year before the culture-related admission (4.85; 1.20-19.61); and (3) cefepime use in the year prior to culture (2.80; 1.03-7.58). In sensitivity analyses, previous mupirocin exposure was associated with low-level [minimum inhibitory concentration (MIC) 8-128mg/L; 23 cases, 202 controls;
OR:
6.32; 95%
CI:
1.58-25.33] and high-level (MIC ≥256mg/L; 17 cases, 151 controls;
OR:
11.18; 95%
CI:
1.89-66.30) mupirocin resistance. To our knowledge, this is the first case-control study to reveal a strong association between previous mupirocin exposure and subsequent mupirocin resistance in MRSA, with demonstrated robustness in low- and high-level mupirocin resistance. Mupirocin susceptibility monitoring is critical for facilities instituting decolonisation with mupirocin as increased use may reduce effectiveness through resistance.

Affiliation

Veterans Affairs Medical Center, Infectious Diseases Research Program, Providence, Rhode Island, USA; University of Rhode Island, Department of Pharmacy Practice, Kingston, Rhode Island, USA.

Journal Details

This article was published in the following journal.

Name: The Journal of hospital infection
ISSN: 1532-2939
Pages:

Links

Medical and Biotech [MESH] Definitions

Tuberculosis, Multidrug-resistant

Tuberculosis resistant to chemotherapy with two or more ANTITUBERCULAR AGENTS, including at least ISONIAZID and RIFAMPICIN. The problem of resistance is particularly troublesome in tuberculous OPPORTUNISTIC INFECTIONS associated with HIV INFECTIONS. It requires the use of second line drugs which are more toxic than the first line regimens. TB with isolates that have developed further resistance to at least three of the six classes of second line drugs is defined as EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS.

Causality

The relating of causes to the effects they produce. Causes are termed necessary when they must always precede an effect and sufficient when they initiate or produce an effect. Any of several factors may be associated with the potential disease causation or outcome, including predisposing factors, enabling factors, precipitating factors, reinforcing factors, and risk factors.

Prediabetic State

The time period before the development of symptomatic diabetes. For example, certain risk factors can be observed in subjects who subsequently develop INSULIN RESISTANCE as in type 2 diabetes (DIABETES MELLITUS, TYPE 2).

Confounding Factors (epidemiology)

Factors that can cause or prevent the outcome of interest, are not intermediate variables, and are not associated with the factor(s) under investigation. They give rise to situations in which the effects of two processes are not separated, or the contribution of causal factors cannot be separated, or the measure of the effect of exposure or risk is distorted because of its association with other factors influencing the outcome of the study.

Drug Resistance, Multiple, Bacterial

The ability of bacteria to resist or to become tolerant to several structurally and functionally distinct drugs simultaneously. This resistance may be acquired through gene mutation or foreign DNA in transmissible plasmids (R FACTORS).

PubMed Articles [ 24138 Associated PubMed Articles listed on BioPortfolio]

Detection of methicillin-resistant Staphylococcus aureus with high-level resistance to mupirocin.

Staphylococcus aureus with high-level mupirocin resistance has rarely been isolated in Japan. We detected methicillin-resistant S. aureus (MRSA) with high-level mupirocin resistance (HLMR-MRSA; MIC â‰...

Evaluation of mupA EVIGENE(R) assay for Determination of High-Level Mupirocin Resistance in Staphylococcus aureus.

Mupirocin is widely used to decolonize patients carrying Staphylococcus aureus, especially methicillin resistant S.aureus (MRSA). The aim of this study was to determine the presence of high-level mupi...

HPLC/MS/MS methodology for sensitive quantitation of monic acid A, the metabolic product of the antibiotic mupirocin.

Patients who are treated by self-medication with intranasal mupiricin (Bactrobanâ„¢) for controlling meticillin-resistant Staphylococcus aureus may, or may not, adhere to their regimen. Herein, we des...

Isolation of meticillin-resistant Staphylococcus aureus (MRSA) from swine in Japan.

Meticillin-resistant Staphylococcus aureus (MRSA) sequence type (ST) 398 is widely prevalent in swine in Europe and North America. To determine the prevalence of MRSA, and specifically ST398, in Japan...

Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.

The objective of this study was to determine whether exposure of Staphylococcus aureus to early (ciprofloxacin or levofloxacin) and a recent fluoroquinolone (moxifloxacin) has differential potential a...

Clinical Trials [ 4194 Associated Clinical Trials listed on BioPortfolio]

Epidemiology of Fluoroquinolone Resistance in Human Commensal Flora in Patients Hospitalised in Medical Wards

Emergence of bacterial resistance to antibiotics, which is a major public health issue, appears to involve predominantly commensal flora. No data exists concerning risk factors for the car...

Infections Caused by ESbL-Producing Enterobacteriaceae in Italy

To assess the molecular epidemiology, clinical impact, treatment outcome and risk factors for infections caused by Enterobacteriaceae producing ESBLs in Italy in a large multicenter observ...

A Prospective Trial of Nasal Mupirocin, Hexachlorophene Body Wash, and Systemic Antibiotics for Prevention of Recurrent Methicillin Resistant Staphylococcus Aureus Infections

This clinical trial tests the hypothesis that body decolonization of patients with recurrent community-associated (CA) MRSA infections will significantly reduce the likelihood of recurrent...

Prospective Study of Drug Resistant Pathogens Among Liver, Intestinal and Multivisceral Transplant Recipients

Infections caused by multidrug resistant bacteria have become more prevalent at many tertiary care and academic centers. These infections are associated with increased morbidity and mortal...

Comparing Tricor, Avandia, or Weight Loss to Lower Cardiovascular Risk Factors in People With High Triglycerides.

Approximately 1/4 of the US population has insulin resistance and the associated risk factors such as elevated lipid levels -triglycerides (type of fat from what we eat and what the liver...

Search BioPortfolio:
Advertisement
Advertisement